Gregory Norden has served on the company's board since March 2019 and is the former Chief Financial Officer of Wyeth Pharmaceuticals Inc. Norden has been Managing Director of G9 Capital Group LLC since 2010.
Holger Lerche is professor of neurology and clinical director of the Department of Neurology and Epileptology at the Hertie Institute for Clinical Brain Research, University and University Clinic of Tübingen, Germany.
Ivan Soltesz is the James R. Doty Professor of Neurosurgery and Neurosciences at Stanford University School of Medicine. His research focuses on neuronal inhibition in the brain and the mechanistic bases of circuit dysfunction in epilepsy.
Jeffrey Kindler has served on the company's board since January 2026 and as Chief Executive Officer of Centrexion Therapeutics Corp. since October 2013. Kindler has been a founding partner and co-chair of the Pioneer Collective since January 2024.
The page lists an address at 99 High Street, 30th Floor, Boston, MA 02110, and the email addresses contact@praxismedicines.com and careers@praxismedicines.com.
Praxis Precision Medicines Inc.'s privacy policy describes the data protection practices of the company and its affiliates, including when visitors use Praxis websites that link to the policy.
